Cargando…
The health and quality of life of Thalidomide survivors as they age – Evidence from a UK survey
BACKGROUND: In the late 1950s and early 1960s the drug Thalidomide was marketed across the world as a non-addictive tranquilizer. Despite being given to pregnant women as a safe treatment for morning sickness, Thalidomide caused serious damage to the unborn child. Much has been written about the dru...
Autores principales: | Newbronner, Elizabeth, Glendinning, Caroline, Atkin, Karl, Wadman, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334953/ https://www.ncbi.nlm.nih.gov/pubmed/30650111 http://dx.doi.org/10.1371/journal.pone.0210222 |
Ejemplares similares
-
Health-related quality of life and function in middle-aged individuals with thalidomide embryopathy
por: Ghassemi Jahani, Shadi A., et al.
Publicado: (2016) -
Loneliness among people with severe mental illness during the COVID-19 pandemic: Results from a linked UK population cohort study
por: Heron, Paul, et al.
Publicado: (2022) -
Quality of life and pain in patients with thalidomide embryopathy in Japan
por: Imai, Koubun, et al.
Publicado: (2020) -
Investigating smoking and nicotine dependence among people with severe mental illness during the COVID-19 pandemic: analysis of linked data from a UK Closing the Gap cohort
por: Peckham, Emily, et al.
Publicado: (2021) -
Sleep health among people with severe mental ill health during the COVID-19 pandemic: Results from a linked UK population cohort study
por: Heron, Paul N., et al.
Publicado: (2022)